This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
The authors have requested that this preprint be withdrawn due to author disagreement.
Yes there is potential Competing Interest.
Fabrice André received research fundings and served as speaker / advisor (compensated to the hospital) for Roche, AstraZeneca, Daiichi Sankyo, Pfizer, Novartis, Lilly.
Anne PATSOURIS received consulting fees (e.g. advisory boards) and served as a speaker (both compensed to the hospital) for Pfizer, Lilly, received travel fees from Roche, Esai, Amgen, Pfizer.
Olivier TREDAN received research grant from Roche, MSD-Merck, BMS, personal fees from Roche, MSD-Merck, Pfizer, Lilly, Astrazeneca, Sandoz, Novartis-Sandoz, Daiichi Sankyo and travel fees from Eli-Lilly, Pfizer, Novartis, Astra Zeneca.
Monica ARNEDOS received research grant from Eli-Lilly, honoria from Pfizer, Novartis, Astra Zeneca, Seattle Genetics and Abbvie, travel fees from Roche, Astra Zeneca and Novartis
Anthony GONCALVES received research fundings and served as speaker / advisor, compensated to the hospital for Astra Zeneca, Pfizer, Novartis, Roche, MSD, Lilly
Cecile VICIER received research grant from BMS and travel fees from Pfizer, Astellas and Roche.
Andrea LOEHR is affiliated to Clovis and a no competing interest to disclose otherwise.